Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012 | Zendy

Jessica Leung | Zendy; Rafael Harpaz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012

Author(s) -

Jessica Leung,

Rafael Harpaz

Publication year - 2015

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piv044

Subject(s) - medicine , vaccination , pediatrics , varicella vaccine , population , chickenpox , retrospective cohort study , chickenpox vaccine , varicella zoster virus , cohort , immunology , immunization , environmental health , virus , antigen

Although the 1-dose varicella vaccination program, introduced in 1996, has led to significant declines in varicella disease, outbreaks continued to occur, which led to the adoption of a 2-dose vaccination program in 2007. We previously reported an 88% decline in varicella-related hospitalizations and a 59% decline in outpatient visits during 1994-2002. We now update data on varicella healthcare utilization with 10 years of additional data, during a period of stabilizing first-dose coverage and rapidly increasing second-dose coverage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research